# mifepristone

Type: Product

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/mifepristone
Canonical HTML page: https://getlegalbrief.com/entity/mifepristone

## Timeline

- **2026-03-19**: Murder Charge Filed — A woman is arrested and charged with murder for self-inducing an abortion with medication.
- **2026-03-13**: Missouri Stay Request — DOJ files request in Missouri court to pause litigation pending FDA review.
- **2026-03-11**: Legislative Action — Senator Josh Hawley introduces a Senate bill to outright ban the abortion pill.
- **2026-01-20**: Louisiana Request — DOJ asks Louisiana court to pause a similar lawsuit; request is largely ignored by the state.
- **2025-11-15**: Amended Complaint — AG Catherine Hanaway files amended complaint targeting mail-order abortion drugs.
- **2025-10-01**: Lawsuit Filed — Missouri, Kansas, and Idaho file suit against the FDA over mifepristone approval.
- **2024-06-13**: SCOTUS Ruling — Supreme Court dismisses challenge to mifepristone access on standing grounds, preserving status quo.
- **2024-03-01**: Retail Pharmacy Entry — Major chains CVS and Walgreens receive certification to dispense abortion pills.
- **2022-07-20**: LIFE Act Implementation — The 11th Circuit Court of Appeals allows Georgia's 6-week ban and personhood provisions to take effect.
- **2022-06-24**: Dobbs Decision — The U.S. Supreme Court overturns Roe v. Wade, allowing state-level bans to take effect.
- **2022-06-24**: Dobbs Decision — Supreme Court overturns Roe v. Wade, leading to state-level bans.
- **2021-12-16**: Telehealth Expansion — FDA permanently removes in-person dispensing requirements, allowing mail-order access.
- **2019-05-07**: LIFE Act Signed — Georgia Governor Brian Kemp signs the Living Infants Fairness and Equality (LIFE) Act.
- **2000-09-28**: Initial FDA Approval — FDA approves Mifepristone for medical termination of early pregnancy.

## Recent coverage (4 stories)

### Medication Abortion Dominates US Landscape Amid Escalating Legal Challenges
2026-03-24 07:42:49 · Sentiment: Neutral · Impact: 7/10 · Sources: 2

Medication abortion now accounts for the majority of pregnancy terminations in the U.S., driven by telehealth expansion and state shield laws. This shift has triggered a wave of regulatory counter-measures from opponents, focusing on the Comstock Act and FDA approval processes.
Full story: https://getlegalbrief.com/story/medication-abortion-regulation-legal-tech-trends

### Georgia Murder Charge for Self-Induced Abortion Signals New Legal Frontier
2026-03-20 01:14:14 · Sentiment: Negative · Impact: 6/10 · Sources: 3

A Georgia woman faces malice murder charges after allegedly using medication to induce an abortion, marking a significant escalation in the criminalization of reproductive care. This case tests the boundaries of state 'fetal personhood' laws and creates a high-stakes precedent for the intersection of digital privacy and law enforcement.
Full story: https://getlegalbrief.com/story/georgia-abortion-murder-charge-analysis

### GOP's 'Clean Water For All Life Act' Targets Abortion Pills via EPA Regulation
2026-03-20 00:33:18 · Sentiment: Negative · Impact: 6/10 · Sources: 3

House Republicans have introduced legislation that would criminalize flushing fetal remains, mandating the use of 'catch kits' for medical abortions to prevent alleged water contamination. The bill represents a novel attempt to use environmental protection frameworks to restrict reproductive healthcare access and ban telehealth services.
Full story: https://getlegalbrief.com/story/gop-clean-water-act-abortion-pill-regulation

### DOJ Seeks Strategic Pause in State-Led Mifepristone Litigation Amid FDA Review
2026-03-13 00:34:01 · Sentiment: Negative · Impact: 8/10 · Sources: 2

The U.S. Department of Justice has requested federal courts in Missouri to pause litigation challenging the FDA's approval of mifepristone, citing an ongoing internal agency review. This tactical shift suggests a preference for administrative rulemaking over high-profile court battles as the administration navigates the legal complexities of reproductive health regulation.
Full story: https://getlegalbrief.com/story/doj-mifepristone-litigation-stay-missouri

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.